http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a96c247671be4cbed54918dfb20dff2b
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Peer |
| name | Cody J Peer Cody J. Peer |
| given-name | Cody J Cody J. |
| organization-name | Clinical Pharmacology Program, National Institutes of Health, Bethesda, Maryland, USA Kevin C. Conlon, Steven A. Rosenberg, Antonio Tito Fojo, John C. Morris, Thomas A. Fleisher, Sigrid P. Dubois, Liyanage P. Perera, Donn M. Stewart, Carolyn K. Goldman, Bonita R. Bryant, Jean M. Decker, Jing Chen, Tat'Yana A. Worthy, William D. Figg Sr, Cody J. Peer, and Thomas A. Waldmann, National Cancer Institute; Enrico Lugli, Hugh C. Welles, Michael C. Sneller, H. Clifford Lane, and Mario Roederer, National Institute of Allergy and Infectious Diseases, Bethesda; Jason L. Yovandich and Stephen P.... Center for Cancer Research, Clinical Pharmacology Program, National Cancer Institute , Bethesda, Maryland , USA Clinical Pharmacology Program, National Cancer Institute National Institutes of Health Bethesda MD USA Clinical Pharmacology Program NCI Bethesda Maryland Russell Z. Szmulewitz, Abiola Ibraheem, Elia Martinez, Mark F. Kozloff, Chadi Nabhan, Theodore Karrison, Walter M. Stadler, and Mark J. Ratain, The University of Chicago, Chicago; Mark F. Kozloff, Ingalls Hospital, Harvey; Paul Fishkin, Illinois Cancer Care, Peoria, IL; Cody J. Peer and William D. Figg, National Cancer Institute, Rockville, MD; Bradley Carthon and R. Donald Harvey, Winship Cancer Institute of Emory University, Atlanta, GA; and Wei Peng Yong and Edmund Chiong, National University Cancer... Clinical Pharmacology Program, Office of the Clinical Director, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher,... 1Medical Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland. Clinical Pharmacology Program National Cancer Institute National Institutes of Health Bethesda Maryland USA Clinical Pharmacology Program, National Cancer Institute, Bethesda, MD, USA Clinical Pharmacology Program National Cancer Institute NIH Bethesda MD Center for Cancer Research, NCI, Bethesda, MD; Clinical Pharmacology Program, National Cancer Institute, Bethesda, MD 4Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. Genitourinary Malignancies Branch, Center for Cancer Research , National Cancer Institute, Bethesda MD 3Clinical Pharmacology Program, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland. Clinical Pharmacology Program National Cancer Institute NIH, Bethesda MD USA Clinical Pharmacology Program, Office of the Clinical Director, Center for Cancer Research National Cancer Institute Bethesda Maryland 7Center for Cancer Research, NCI, NIH, Bethesda, Maryland. Authors' Affiliations: 1Medical Oncology Branch, Center for Cancer Research, NCI, 2Department of Cardiology, Washington Hospital Center, 3Radiology and Imaging Sciences, NIH Clinical Center, 4Biostatistics and Data Management Section, NCI, 5Cancer Therapy Evaluation Program, NCI, and 6Clinical Endocrine Section, NIDDK, NIH, Bethesda, Maryland 1Clinical Pharmacology Program, Office of the Clinical Director, NCI, Bethesda, Maryland. Clinical Pharmacology Program, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, United States 3Clinical Pharmacology Program, Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland. Genitourinary Malignancies Branch NCI Bethesda MD USA 2Clinical Pharmacology Program, Center for Cancer Research, NCI, Bethesda, Maryland. Genitourinary Malignancies Branch Center for Cancer Research National Cancer Institute Bethesda MD USA 1Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Clinical Pharmacology Program National Cancer Institute Bethesda MD USA Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA 8Clinical Pharmacology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland. Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD; Leidos Biomedical Research, Frederick, Maryland Clinical Pharmacology Program National Cancer Institute Bethesda Maryland USA 5Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland. Clinical Pharmacology Program National Cancer Institute, National Institutes of Health Bethesda Maryland USA Authors' Affiliations: 1Clinical Pharmacology Program, 2Pharmacology and Experimental Therapeutics Section, 3Molecular Pharmacology Section, 4Biostatistics and Data Management Branch, 5Medical Oncology Branch, and 6HIV/AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland Clinical Pharmacology Program, Center for Cancer Research National Cancer Institute, National Institutes of Health Bethesda Maryland USA Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute National Institutes of Health Bethesda Maryland 3Clinical Pharmacology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland. From the Pediatric Oncology Branch (A.M.G., P.L.W., E.D., P.W., S.M., M.C.R., D.C.P., A.C., J.T., O.K., J.G., B.C.W.) and the Clinical Pharmacology Program (C.J.P., W.D.F.), Center for Cancer Research, National Cancer Institute, and the Rehabilitation Medicine Department, Clinical Center (S.M.P), National Institutes of Health, Bethesda, the Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick (A.B., K.H.), the Cancer... Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA 7Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland. Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD , USA Mark N. Polizzotto, Thomas S. Uldrick, Kathleen M. Wyvill, Karen Aleman, Cody J. Peer, Frank Maldarelli, Priscila H. Goncalves, William D. Figg, Seth M. Steinberg, and Robert Yarchoan, National Cancer Institute; Margaret Bevans, National Institutes of Health; Irini Sereti, National Institute of Allergy and Infectious Diseases, Bethesda, MD; Denise Whitby and Vickie Marshall, Frederick National Cancer Laboratory for Cancer Research, Frederick, MD; and Vikram Khetani and Jerome B. Zeldis, Celgene... Clinical Pharmacology Program Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda Maryland |
Incoming Links
Total number of triples: 161.